Korean J Fam Pract 2019; 9(2): 147-153  https://doi.org/10.21215/kjfp.2019.9.2.147
The Association between High Sensitivity C-Reactive Protein and Homeostasis Model Assessment of Insulin Resistance in Non-Diabetetic Korean Men
Young Eun Kwon, Sang Wha Lee*, Hong Soo Lee, Kyung Won Shim, A Ri Byun, Sun Young Park
Department of Familial Medicine, Ewha Womens University Mokdong Hospital, Ewha Womens University Schoool of Medicine, Seoul, Korea
Sang Wha Lee, Tel: +82-2-2650-5165, Fax: +82-2-2654-2439, E-mail: ghwa@ewha.ac.kr, ORCID: http://orcid.org/0000-0002-7451-9978
Received: May 9, 2018; Revised: November 19, 2018; Accepted: December 26, 2018; Published online: April 20, 2019.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: Insulin resistance syndrome is recognized as a risk factor for cardiovascular disease (CVD) and type 2 diabetes mellitus (DM). Even though early management and prevention during the pre-DM stage is emphasized, few studies have investigated the risk of insulin resistance and CVD in individuals with normal blood glucose. This study investigates the effectiveness of the high sensitivity C-reactive protein (hs-CRP) test as a preventative measure by examining the relationship between hs-CRP and a homeostasis model assessment of insulin resistance (HOMA-IR) in adult men without DM.
Methods: Our study included 1,924 men who were ≥20 years of age, from the 2015 Korean National Health and Nutrition Examination Survey. Based on fasting glucose levels, subjects were divided into two categories: normal and impaired fasting glucose (IFG).
Results: Student’s t-test was used to compare the means of the normal and IFG categories, and hs-CRP and HOMA-IR showed significantly lower values for all variations, except height and smoking, at a significance level of 0.001. All subjects were classified into quadrant groups according to hs-CRP values, and ANCOVA was performed to compare the HOMA-IR average of each group. The mean IR did not significantly differ between cohorts, except for in the IFG category of one group.
Conclusion: In adult men without DM, hs-CRP did not significantly correlate with HOMA-IR, except in the IFG category. This indicates that the risk of CVD increases continuously in the normal blood sugar range. Further studies are needed to improve the usefulness of the high sensitivity hs-CRP test.
Keywords: High Sensitivity C-Reactive Protein; Homeostasis Model Assessment of Insulin Resistance; Insulin Resistance
References
  1. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-6.
    Pubmed CrossRef
  2. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003; 46: 1594-603.
    Pubmed CrossRef
  3. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47: 412-26.
    Pubmed
  4. Kawamura M, Heinecke JW, Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest 1994; 94: 771-8.
    Pubmed KoreaMed CrossRef
  5. Fuster V, Gotto AM Jr. Risk reduction. Circulation 2000; 102(20 Suppl 4):IV94-102.
    Pubmed CrossRef
  6. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109(21 Suppl 1): II2-10.
    CrossRef
  7. Ridker PM, Rifai N, Clearfield M, Downs JR, Weis SE, Miles JS, et al.; Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344: 1959-65.
    Pubmed CrossRef
  8. Ministry of Health Welfare. Korea health statistics 2014: Korea national health and nutrition examination survey(KNHANES IV-6). Osong: Korea Centers for Disease Control and Prevention: 2015.
  9. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
    Pubmed CrossRef
  10. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002; 19: 527-34.
    Pubmed CrossRef
  11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
    Pubmed CrossRef
  12. Lee S, Choi S, Kim HJ, Chung YS, Lee KW, Lee HC, et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006; 21: 695-700.
    Pubmed KoreaMed CrossRef
  13. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607.
    Pubmed CrossRef
  14. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, SuttonTyrrell K, et al. Inflammatory markers and onset of cardiovascular events:results from the Health ABC study. Circulation 2003; 108: 2317-22.
    Pubmed CrossRef
  15. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, et al. CReactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-42.
    Pubmed CrossRef
  16. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241-8.
    Pubmed CrossRef
  17. Festa A, D’Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42-7.
    Pubmed CrossRef
  18. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001; 24: 460-4.
    Pubmed CrossRef
  19. Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002; 40: 937-43.
    Pubmed CrossRef
  20. Omar MA, Seedat MA, Dyer RB, Motala AA, Knight LT, Becker PJ. South African Indians show a high prevalence of NIDDM and bimodality in plasma glucose distribution patterns. Diabetes Care 1994; 17: 70-3.
    Pubmed CrossRef
  21. de Marco R, Locatelli F, Zoppini G, Verlato G, Bonora E, Muggeo M. Causespecific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 1999; 22: 756-61.
    Pubmed CrossRef
  22. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-5.
    Pubmed KoreaMed CrossRef
  23. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 2003; 108: 161-5.
    Pubmed CrossRef
  24. Bjørnholt JV, Erikssen G, Aaser E, Sandvik L, Nitter-Hauge S, Jervell J, et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 1999; 22: 45-9.
    Pubmed CrossRef
  25. Yun YS, Park SW, Song YD, Park HK, Kim OY, Ahn CW, et al. Limitation of validity of homeostasis model assessment as a index of insulin resistance. J Korean Diabetes Assoc 2000; 24: 541-51.
  26. Kang ES, Yun YS, Park SW, Kim HJ, Ahn CW, Song YD, et al. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metabolism 2005; 54: 206-11.
    Pubmed CrossRef
  27. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15:74-80.
    Pubmed CrossRef
  28. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care 1998; 21: 649-54.
    Pubmed CrossRef
  29. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-200.
    Pubmed CrossRef


This Article

e-submission

Archives